TrialJAMA oncology2022

Quality-of-Life Outcomes and Toxic Effects Among Patients With Cancers of the Uterus Treated With Stereotactic Pelvic Adjuvant Radiation Therapy: The SPARTACUS Phase 1/2 Nonrandomized Controlled Trial.

Eric Leung et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.